19364969

Source:http://linkedlifedata.com/resource/pubmed/id/19364969

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0016055, umls-concept:C0021756, umls-concept:C0078058, umls-concept:C0087111, umls-concept:C0205210, umls-concept:C0229671, umls-concept:C0681842, umls-concept:C0871261, umls-concept:C1171892, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	16
pubmed:dateCreated	2009-5-29
pubmed:abstractText	High-dose interleukin-2 (IL-2) induces durable therapeutic responses in a small subset of patients with metastatic melanoma and renal cell carcinoma, but simple pretreatment predictors of response have not been identified.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-10700174, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-12097256, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-12114318, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-12184809, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-12586633, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-15102596, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-15781657, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-15897451, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-15897553, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-15897568, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-16113605, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-16342236, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-16369561, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-16407877, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-16433902, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-16505437, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-16946711, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-17008606, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-17013089, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-17255299, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-17562357, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-18079435, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-18197806, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-18463380, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-18483368, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-19364958, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-19895241, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-3041925, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-4938153, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-8837607, http://linkedlifedata.com/resource/pubmed/commentcorrection/19364969-9798082
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Fibronectins, http://linkedlifedata.com/resource/pubmed/chemical/IL2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/VEGFA protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1527-7755
pubmed:author	pubmed-author:DeraffeleGailG, pubmed-author:KaufmanHoward LHL, pubmed-author:Kim-SchulzeSeungheeS, pubmed-author:KimDae WonDW, pubmed-author:MarincolaFrancesco MFM, pubmed-author:PanelliMonica CMC, pubmed-author:PosZoltanZ, pubmed-author:SabatinoMariannaM, pubmed-author:StroncekDavidD, pubmed-author:TabackBretB, pubmed-author:WangEnaE
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	27
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2645-52
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:19364969-Humans, pubmed-meshheading:19364969-Skin Neoplasms, pubmed-meshheading:19364969-Prospective Studies, pubmed-meshheading:19364969-Aged, pubmed-meshheading:19364969-Kidney Neoplasms, pubmed-meshheading:19364969-Female, pubmed-meshheading:19364969-Male, pubmed-meshheading:19364969-Melanoma, pubmed-meshheading:19364969-Adult, pubmed-meshheading:19364969-Carcinoma, Renal Cell, pubmed-meshheading:19364969-Antineoplastic Agents, pubmed-meshheading:19364969-Middle Aged, pubmed-meshheading:19364969-Reproducibility of Results, pubmed-meshheading:19364969-Time Factors, pubmed-meshheading:19364969-Young Adult, pubmed-meshheading:19364969-Patient Selection, pubmed-meshheading:19364969-Cluster Analysis, pubmed-meshheading:19364969-Treatment Failure, pubmed-meshheading:19364969-Risk Assessment, pubmed-meshheading:19364969-Predictive Value of Tests, pubmed-meshheading:19364969-Tumor Markers, Biological

More...